Amal
BSE: AMAL · Specialty Chemicals
Snapshot
Unlock Amal's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Amal Ltd. is an Indian specialty chemicals company primarily engaged in the manufacturing and marketing of bulk chemicals. Its product portfolio includes sulphuric acid, oleum, sulphur dioxide, and sulphur trioxide.
Business Model
The company generates revenue through the large-scale production and sale of industrial chemicals used as raw materials in various downstream manufacturing processes.
- Founded:1974
Growth Outlook
Growth is primarily driven by industrial demand for sulphuric acid and related sulphur-based derivatives across the Indian manufacturing sector.
Key Risks
- Raw Material Price Volatility. Fluctuations in the cost of sulphur and other feedstocks can significantly impact operating margins.
- Regulatory and Environmental Compliance. The chemical manufacturing sector is subject to stringent environmental regulations that may necessitate capital-intensive upgrades.
- Cyclical Demand. As a producer of bulk chemicals, the company is exposed to the cyclical nature of the industrial and manufacturing sectors it serves.
Start your research today
Unlock AI insights, financials, peers and live data on Amal and 5,000+ companies — free.
Key Metrics
REVENUE
₹240 Cr
TTM · consolidated
NET PROFIT
₹22 Cr
TTM · consolidated
EPS
₹18.11
TTM · consolidated
RETURN ON EQUITY
21.4%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
26.8%
TTM · consolidated
P/E
41.0x
Q4 FY26 · consolidated
EV/EBITDA
24.2x
Q4 FY26 · consolidated
EBITDA MARGIN
15.8%
TTM · consolidated
NET PROFIT MARGIN
2.5%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.0x
Q4 FY26 · consolidated
Peers · Specialty Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
AmalAMAL | ₹919 Cr | 41.04 | 24.18 | 77.1% | 15.8% | 21.4% | 26.8% | -19.5% |
Sudarshan Pharma Industries LimitedSUDARSHAN | ₹984 Cr | 40.22 | 21.10 | — | 8.5% | 15.1% | 30.3% | +22.8% |
Indo AminesINDOAMIN | ₹914 Cr | 11.41 | 7.68 | 13.2% | 12.7% | 22.9% | 30.3% | -13.2% |
Valiant Organics Ltd.VALIANTORG | ₹884 Cr | 16.53 | 9.96 | 1.4% | 14.9% | 7.3% | 9.4% | -5.3% |
Gem AromaticsGEMAROMA | ₹844 Cr | -65.92 | 34.13 | — | 7.6% | -3.2% | -0.2% | -40.3% |
Fairchem OrganicFAIRCHEMOR | ₹832 Cr | 58.33 | 25.58 | 0.1% | 7.1% | 5.1% | 7.8% | -16.7% |
As of Q4 FY26
Financials
Amal
BSE: AMAL · Specialty Chemicals
Snapshot
Unlock Amal's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Amal Ltd. is an Indian specialty chemicals company primarily engaged in the manufacturing and marketing of bulk chemicals. Its product portfolio includes sulphuric acid, oleum, sulphur dioxide, and sulphur trioxide.
Business Model
The company generates revenue through the large-scale production and sale of industrial chemicals used as raw materials in various downstream manufacturing processes.
- Founded:1974
Growth Outlook
Growth is primarily driven by industrial demand for sulphuric acid and related sulphur-based derivatives across the Indian manufacturing sector.
Key Risks
- Raw Material Price Volatility. Fluctuations in the cost of sulphur and other feedstocks can significantly impact operating margins.
- Regulatory and Environmental Compliance. The chemical manufacturing sector is subject to stringent environmental regulations that may necessitate capital-intensive upgrades.
- Cyclical Demand. As a producer of bulk chemicals, the company is exposed to the cyclical nature of the industrial and manufacturing sectors it serves.
Start your research today
Unlock AI insights, financials, peers and live data on Amal and 5,000+ companies — free.
Key Metrics
REVENUE
₹240 Cr
TTM · consolidated
NET PROFIT
₹22 Cr
TTM · consolidated
EPS
₹18.11
TTM · consolidated
RETURN ON EQUITY
21.4%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
26.8%
TTM · consolidated
P/E
41.0x
Q4 FY26 · consolidated
EV/EBITDA
24.2x
Q4 FY26 · consolidated
EBITDA MARGIN
15.8%
TTM · consolidated
NET PROFIT MARGIN
2.5%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.0x
Q4 FY26 · consolidated
Peers · Specialty Chemicals
As of Q4 FY26